{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:39:04Z","timestamp":1794976744157,"version":"4.9.1"},"reference-count":100,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Septic shock is mainly characterized\u2014in addition to hypovolemia\u2014by vasoplegia as a consequence of a release of inflammatory mediators. Systemic vasodilatation due to depressed vascular tone results in arterial hypotension, which induces or worsens organ hypoperfusion. Accordingly, vasopressor therapy is mandatory to correct hypotension and to reverse organ perfusion due to hypotension. Currently, two vasopressors are recommended to be used, norepinephrine and vasopressin. Norepinephrine, an \u03b11-agonist agent, is the first-line vasopressor. Vasopressin is suggested to be added to norepinephrine in cases of inadequate mean arterial pressure instead of escalating the doses of norepinephrine. However, some questions about the bedside use of these vasopressors remain. Some of these questions have been well answered, some of them not clearly addressed, and some others not yet answered. Regarding norepinephrine, we firstly reviewed the arguments in favor of the choice of norepinephrine as a first-line vasopressor. Secondly, we detailed the arguments found in the recent literature in favor of an early introduction of norepinephrine. Thirdly, we reviewed the literature referring to the issue of titrating the doses of norepinephrine using an individualized resuscitation target, and finally, we addressed the issue of escalation of doses in case of refractory shock, a remaining unanswered question. For vasopressin, we reviewed the rationale for adding vasopressin to norepinephrine. Then, we discussed the optimal time for vasopressin administration. Subsequently, we addressed the issue of the optimal vasopressin dose, and finally we discussed the best strategy to wean these two vasopressors when combined.<\/jats:p>","DOI":"10.3390\/jcm12144589","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T01:58:14Z","timestamp":1689040694000},"page":"4589","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock"],"prefix":"10.3390","volume":"12","author":[{"given":"Olfa","family":"Hamzaoui","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine intensive r\u00e9animation polyvalente, H\u00f4pital Robert Debr\u00e9, CHU de Reims Universit\u00e9 de Reims, 51092 Reims, France"},{"name":"\u201cH\u00e9mostase et Remodelage Vasculaire Post-Isch\u00e9mie\u201d\u2014EA 3801, Unit\u00e9 HERVI, 51100 Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Goury","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine intensive r\u00e9animation polyvalente, H\u00f4pital Robert Debr\u00e9, CHU de Reims Universit\u00e9 de Reims, 51092 Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Teboul","sequence":"additional","affiliation":[{"name":"Service de m\u00e9decine intensive-r\u00e9animation, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris-Saclay, DMU CORREVE, FHU SEPSIS, 94270 Le Kremlin-Bic\u00eatre, France"},{"name":"INSERM-UMR_S999 LabEx\u2014LERMIT, H\u00f4pital Marie-Lannelongue, 92350 Le Plessis Robinson, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.23736\/S0375-9393.18.12422-9","article-title":"Fluid resuscitation during early sepsis: A need for individualization","volume":"84","author":"Jozwiak","year":"2018","journal-title":"Minerva Anestesiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"H660","DOI":"10.1152\/ajpheart.1993.264.2.H660","article-title":"Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats","volume":"264","author":"Hollenberg","year":"1993","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00134-005-2688-z","article-title":"Hemodynamic variables related to outcome in septic shock","volume":"31","author":"Varpula","year":"2005","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","article-title":"Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study","volume":"33","author":"Leone","year":"2005","journal-title":"Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1097\/01.CCM.0000181297.14319.3C","article-title":"Cardiovascular response to dopamine and early prediction of outcome in septic shock: A prospective multiple-center study","volume":"33","author":"Levy","year":"2005","journal-title":"Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Scheeren, T.W.L., Bakker, J., De Backer, D., Annane, D., Asfar, P., Boerma, E.C., Cecconi, M., Dubin, A., D\u00fcnser, M.W., and Duranteau, J. (2019). Current use of vasopressors in septic shock. Ann. Intensive Care, 9.","DOI":"10.1186\/s13613-019-0498-7"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of Dopamine and Norepinephrine in the Treatment of Shock","volume":"362","author":"Biston","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0b013e31823778ee","article-title":"Dopamine versus norepinephrine in the treatment of septic shock","volume":"40","author":"Aldecoa","year":"2012","journal-title":"Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Avni, T., Lador, A., Lev, S., Leibovici, L., Paul, M., and Grossman, A. (2015). Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129305"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00134-015-3898-7","article-title":"Effects of fluid administration on arterial load in septic shock patients","volume":"41","author":"Romero","year":"2015","journal-title":"Intensive Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/01.CIR.91.5.1314","article-title":"Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo","volume":"91","author":"Joannides","year":"1995","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1007\/s00134-010-2013-3","article-title":"Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients","volume":"36","author":"Georger","year":"2010","journal-title":"Intensive Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"653.e9","DOI":"10.1016\/j.jcrc.2015.01.014","article-title":"A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters","volume":"30","author":"Loubani","year":"2015","journal-title":"J. Crit. Care"},{"key":"ref_15","first-page":"1060","article-title":"Risk of Major Complications After Perioperative Norepinephrine Infusion Through Peripheral Intravenous Lines in a Multicenter Study","volume":"131","author":"Pancaro","year":"2019","journal-title":"Obstet. Anesthesia Dig."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Vincent, J.-L., Singer, M., Einav, S., Moreno, R., Wendon, J., Teboul, J.-L., Bakker, J., Hernandez, G., Annane, D., and de Man, A.M.E. (2021). Equilibrating SSC guidelines with individualized care. Crit. Care, 25.","DOI":"10.1186\/s13054-021-03813-0"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00134-021-06595-9","article-title":"Current practice and evolving concepts in septic shock resuscitation","volume":"48","author":"Bakker","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.36.5.801","article-title":"Systolic and Diastolic Blood Pressure, Pulse Pressure, and Mean Arterial Pressure as Predictors of Cardiovascular Disease Risk in Men","volume":"36","author":"Sesso","year":"2000","journal-title":"Hypertension"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00134-007-0738-4","article-title":"Contribution of arterial stiffness and stroke volume to peripheral pulse pressure in ICU patients: An arterial tonometry study","volume":"33","author":"Lamia","year":"2007","journal-title":"Intensive Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jcrc.2018.10.032","article-title":"Importance of diastolic arterial pressure in septic shock: PRO","volume":"51","author":"Hamzaoui","year":"2018","journal-title":"J. Crit. Care"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hamzaoui, O., Georger, J.-F., Monnet, X., Ksouri, H., Maizel, J., Richard, C., and Teboul, J.-L. (2010). Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit. Care, 14.","DOI":"10.1186\/cc9207"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/CCM.0b013e318206d2a3","article-title":"Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients","volume":"39","author":"Monnet","year":"2011","journal-title":"Crit. Care Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bja.2017.11.065","article-title":"Norepinephrine exerts an inotropic effect during the early phase of human septic shock","volume":"120","author":"Hamzaoui","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1097\/CCM.0b013e318260c6c3","article-title":"Effects of norepinephrine on mean systemic pressure and venous return in human septic shock","volume":"40","author":"Persichini","year":"2012","journal-title":"Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Adda, I., Lai, C., Teboul, J.-L., Guerin, L., Gavelli, F., and Monnet, X. (2021). Norepinephrine potentiates the efficacy of volume expansion on mean systemic pressure in septic shock. Crit. Care, 25.","DOI":"10.1186\/s13054-021-03711-5"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Espinoza, E.D.V., Hernandez, G., and Bakker, J. (2019). Norepinephrine, more than a vasopressor. Ann. Transl. Med., 7.","DOI":"10.21037\/atm.2019.01.76"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ospina-Tasc\u00f3n, G.A., Hernandez, G., Alvarez, I., Calder\u00f3n-Tapia, L.E., Manzano-Nunez, R., S\u00e1nchez-Ortiz, A.I., Qui\u00f1ones, E., Ruiz-Yucuma, J.E., Aldana, J.L., and Teboul, J.-L. (2020). Effects of very early start of norepinephrine in patients with septic shock: A propensity score-based analysis. Crit. Care, 24.","DOI":"10.1186\/s13054-020-2756-3"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/CCM.0000000000002189","article-title":"Higher Fluid Balance Increases the Risk of Death from Sepsis","volume":"45","author":"Sakr","year":"2017","journal-title":"Crit. Care Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bai, X., Yu, W., Ji, W., Lin, Z., Tan, S., Duan, K., Dong, Y., Xu, L., and Li, N. (2014). Early versus delayed administration of norepinephrine in patients with septic shock. Crit. Care, 18.","DOI":"10.1186\/s13054-014-0532-y"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","article-title":"Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial","volume":"199","author":"Permpikul","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Li, Y., Li, H., and Zhang, D. (2020). Timing of norepinephrine initiation in patients with septic shock: A systematic review and meta-analysis. Crit. Care, 24.","DOI":"10.1186\/s13054-020-03204-x"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1097\/00003246-200008000-00007","article-title":"Effects of perfusion pressure on tissue perfusion in septic shock","volume":"28","author":"LeDoux","year":"2000","journal-title":"Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.CCM.0000157788.20591.23","article-title":"Increasing mean arterial pressure in patients with septic shock: Effects on oxygen variables and renal function","volume":"33","author":"Bourgoin","year":"2005","journal-title":"Crit. Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Dubin, A., Pozo, M.O., Casabella, C.A., P\u00e1lizas, F., Murias, G., Moseinco, M.C., Edul, V.S.K., Estenssoro, E., and Ince, C. (2009). Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: A prospective study. Crit. Care, 13.","DOI":"10.1186\/cc7922"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/CCM.0b013e3181a00a1c","article-title":"The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock","volume":"37","author":"Jhanji","year":"2009","journal-title":"Crit. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Thooft, A., Favory, R., Salgado, D.R., Taccone, F.S., Donadello, K., De Backer, D., Creteur, J., and Vincent, J.-L. (2011). Effects of changes in arterial pressure on organ perfusion during septic shock. Crit. Care, 15.","DOI":"10.1186\/cc10462"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/CCM.0000000000003795","article-title":"Effect of Increasing Blood Pressure with Noradrenaline on the Microcirculation of Patients with Septic Shock and Previous Arterial Hypertension","volume":"47","author":"Coimbra","year":"2019","journal-title":"Crit. Care Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jozwiak, M., Chambaz, M., Sentenac, P., Monnet, X., and Teboul, J.-L. (2020). Assessment of tissue oxygenation to personalize mean arterial pressure target in patients with septic shock. Microvasc. Res., 132.","DOI":"10.1016\/j.mvr.2020.104068"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus Low Blood-Pressure Target in Patients with Septic Shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2020.0930","article-title":"Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients with Vasodilatory Hypotension","volume":"323","author":"Lamontagne","year":"2020","journal-title":"JAMA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/bmj.1.5852.507","article-title":"Autoregulation of Brain Circulation in Severe Arterial Hypertension","volume":"1","author":"Strandgaard","year":"1973","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Tran, P.N.T., Kusirisin, P., Kaewdoungtien, P., Phannajit, J., and Srisawat, N. (2022). Higher blood pressure versus normotension targets to prevent acute kidney injury: A systematic review and meta-regression of randomized controlled trials. Crit. Care, 26.","DOI":"10.1186\/s13054-022-04236-1"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ostermann, M., Hall, A., and Crichton, S. (2017). Low mean perfusion pressure is a risk factor for progression of acute kidney injury in critically ill patients\u2014A retrospective analysis. BMC Nephrol., 18.","DOI":"10.1186\/s12882-017-0568-8"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Vellinga, N.A., Ince, C., and Boerma, E.C. (2013). Elevated central venous pressure is associated with impairment of microcirculatory blood flow in sepsis: A hypothesis generating post hoc analysis. BMC Anesthesiol., 13.","DOI":"10.1186\/1471-2253-13-17"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s00134-022-06835-6","article-title":"Central venous pressure (CVP)","volume":"48","author":"Hamzaoui","year":"2022","journal-title":"Intensive Care Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"H1038","DOI":"10.1152\/ajpheart.1990.259.4.H1038","article-title":"Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway","volume":"259","author":"Gray","year":"1990","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-010-2045-8","article-title":"Vascular hyporesponsiveness to vasopressors in septic shock: From bench to bedside","volume":"36","author":"Levy","year":"2010","journal-title":"Intensive Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/CCM.0000000000000333","article-title":"Serious Adverse Events Associated with Vasopressin and Norepinephrine Infusion in Septic Shock","volume":"42","author":"Anantasit","year":"2014","journal-title":"Crit. Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"Norepinephrine","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Auchet, T., Regnier, M.-A., Girerd, N., and Levy, B. (2017). Outcome of patients with septic shock and high-dose vasopressor therapy. Ann. Intensive Care, 7.","DOI":"10.1186\/s13613-017-0261-x"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.chest.2022.07.018","article-title":"The Relationship Between Norepinephrine Equivalent Dose of Vasopressors Within 24 Hours from the Onset of Septic Shock and In-Hospital Mortality Rate","volume":"163","author":"Sato","year":"2022","journal-title":"Chest"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2125.1998.00833.x","article-title":"Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve","volume":"46","author":"Annane","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Bagate, F., Coppens, A., Masi, P., de Prost, N., Carteaux, G., Razazi, K., and Dessap, A.M. (2022). Cardiac and vascular effects of low-dose steroids during the early phase of septic shock: An echocardiographic study. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.948231"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone","volume":"26","author":"Bollaert","year":"1998","journal-title":"Crit. Care Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus Fludrocortisone for Adults with Septic Shock","volume":"378","author":"Annane","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive Glucocorticoid Therapy in Patients with Septic Shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1113\/jphysiol.1895.sp000565","article-title":"On the Physiological Action of Extracts of Pituitary Body and certain other Glandular Organs","volume":"18","author":"Oliver","year":"1895","journal-title":"J. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1043-2760(00)00304-0","article-title":"Vasopressin Receptors","volume":"11","author":"Birnbaumer","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajem.2005.02.055","article-title":"Low plasma vasopressin\/norepinephrine ratio predicts septic shock","volume":"23","author":"Lin","year":"2005","journal-title":"Am. J. Emerg. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","article-title":"Circulating vasopressin levels in septic shock","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit. Care Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003246-200203000-00001","article-title":"Depletion of neurohypophyseal content of vasopressin in septic shock","volume":"30","author":"Sharshar","year":"2002","journal-title":"Crit. Care Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock","volume":"358","author":"Russell","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1164\/rccm.201604-0862CP","article-title":"Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis","volume":"194","author":"Stolk","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","article-title":"Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis","volume":"202","author":"Stolk","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress","volume":"24","author":"Hasibeder","year":"2009","journal-title":"J. Intensive Care Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1074248417708618","article-title":"Drug-Induced Takotsubo Cardiomyopathy","volume":"22","author":"Kido","year":"2017","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jointm.2022.05.001","article-title":"Alternatives to norepinephrine in septic shock: Which agents and when?","volume":"2","author":"Jozwiak","year":"2022","journal-title":"J. Intensive Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"F274","DOI":"10.1152\/ajprenal.1989.256.2.F274","article-title":"Renal microvascular effects of vasopressin and vasopressin antagonists","volume":"256","author":"Edwards","year":"1989","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1996.101","article-title":"Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles","volume":"49","author":"Tamaki","year":"1996","journal-title":"Kidney Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","article-title":"Beneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock","volume":"96","author":"Patel","year":"2002","journal-title":"Anesthesiology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients with Septic Shock","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: An individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/CCM.0000000000004023","article-title":"Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients","volume":"47","author":"Hajjar","year":"2019","journal-title":"Crit. Care Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation with Mortality in Patients with Septic Shock","volume":"50","author":"Sacha","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/SHK.0000000000001978","article-title":"Early initiation of vasopressin reduces organ failure and mortality in septic shock","volume":"58","author":"Rydz","year":"2022","journal-title":"Shock"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1152\/ajplegacy.1966.210.5.933","article-title":"Effects of angiotensin, epinephrine, norepinephrine, and vasopressin on venous return","volume":"210","author":"Emerson","year":"1966","journal-title":"Am. J. Physiol. Content"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1172\/JCI113613","article-title":"Cardiac and peripheral circulatory responses to angiotension and vasopressin in dogs","volume":"82","author":"Lee","year":"1988","journal-title":"J. Clin. Investig."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"H493","DOI":"10.1152\/ajpheart.1991.261.2.H493","article-title":"Whole body vascular capacitance response to vasopressin is mediated by autonomic function","volume":"261","author":"Martin","year":"1991","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s001340101014","article-title":"The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series","volume":"27","author":"Holmes","year":"2001","journal-title":"Intensive Care Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","article-title":"Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial","volume":"32","author":"Lauzier","year":"2006","journal-title":"Intensive Care Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.1097\/01.CCM.0000279158.51481.41","article-title":"Vasopressin in septic shock","volume":"35","author":"Russell","year":"2007","journal-title":"Crit. Care Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1592\/phco.28.5.591","article-title":"Lack of an Effect of Body Mass on the Hemodynamic Response to Arginine Vasopressin During Septic Shock","volume":"28","author":"Lam","year":"2008","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1097\/01.CCM.0000281853.50661.23","article-title":"Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock","volume":"35","author":"Luckner","year":"2007","journal-title":"Crit. Care Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00134-009-1630-1","article-title":"Comparing two different arginine vasopressin doses in advanced vasodilatory shock: A randomized, controlled, open-label trial","volume":"36","author":"Torgersen","year":"2009","journal-title":"Intensive Care Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.CCM.0000059722.94182.79","article-title":"Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors","volume":"31","author":"Mayr","year":"2003","journal-title":"Crit. Care Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Jiang, L., Sheng, Y., Feng, X., and Wu, J. (2019). The effects and safety of vasopressin receptor agonists in patients with septic shock: A meta-analysis and trial sequential analysis. Crit. Care, 23.","DOI":"10.1186\/s13054-019-2362-4"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/phar.2265","article-title":"Effects of Norepinephrine and Vasopressin Discontinuation Order in the Recovery Phase of Septic Shock: A Systematic Review and Individual Patient Data Meta-Analysis","volume":"39","author":"Hammond","year":"2019","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Jeon, K., Song, J.-U., Chung, C.R., Yang, J.H., and Suh, G.Y. (2018). Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: A prospective randomized trial (DOVSS). Crit. Care, 22.","DOI":"10.1186\/s13054-018-2034-9"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SHK.0b013e318033e5da","article-title":"Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock","volume":"28","author":"Morgenthaler","year":"2007","journal-title":"Shock"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2362.2007.01762.x","article-title":"Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections","volume":"37","author":"Morgenthaler","year":"2007","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Gomes, D.A., Beltr\u00e3o, R.L.D.A., Junior, F.M.D.O., Junior, J.C.D.S., de Arruda, E.P.C., Lira, E.C., and da Rocha, M.J.A. (2020). Vasopressin and copeptin release during sepsis and septic shock. Peptides, 136.","DOI":"10.1016\/j.peptides.2020.170437"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1210\/jc.2005-2830","article-title":"Copeptin and Arginine Vasopressin Concentrations in Critically Ill Patients","volume":"91","author":"Jochberger","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/CCM.0b013e3181957532","article-title":"The vasopressin and copeptin response to infection, severe sepsis, and septic shock","volume":"37","author":"Jochberger","year":"2009","journal-title":"Crit. Care Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the Treatment of Vasodilatory Shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II Infusion for Shock","volume":"159","author":"Wieruszewski","year":"2020","journal-title":"Chest"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Zhao, C.-C., Zhai, Y.-J., Hu, Z.-J., Huo, Y., Li, Z.-Q., and Zhu, G.-J. (2022). Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis. Front. Med., 9.","DOI":"10.3389\/fmed.2022.950596"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ibarra-Estrada, M., Kattan, E., Aguilera-Gonz\u00e1lez, P., Sandoval-Plascencia, L., Rico-Jauregui, U., G\u00f3mez-Partida, C.A., Ortiz-Mac\u00edas, I.X., L\u00f3pez-Pulgar\u00edn, J.A., Ch\u00e1vez-Pe\u00f1a, Q., and Mijangos-M\u00e9ndez, J.C. (2023). Early adjunctive methylene blue in patients with septic shock: A randomized controlled trial. Crit. Care, 27.","DOI":"10.1186\/s13054-023-04397-7"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00134-017-4909-7","article-title":"Intensive care medicine in 2050: Vasopressors in sepsis","volume":"44","author":"Teboul","year":"2017","journal-title":"Intensive Care Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/14\/4589\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:10:02Z","timestamp":1760127002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/14\/4589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":100,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["jcm12144589"],"URL":"https:\/\/doi.org\/10.3390\/jcm12144589","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]}}}